← All trials
NCT00643045
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2004
- Primary completion
- Jan 1, 2006
- Completion date
- Jul 1, 2007
- First posted
- —
- Last posted
- —
- Enrollment
- 269
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Newron PharmaceuticalsLead sponsor
- Liga Chilena Contra el Mal De Parkinson, Santiago, ChileOverall official - principal investigator
- Hospital Salvador-Neurologia, Santiago, ChileOverall official - principal investigator
- Osp. S. Giovanni Battista, Roma, ItalyOverall official - principal investigator
- Cura Villa Margherita, Vicenza, ItalyOverall official - principal investigator
- Ospedale Evangelico ValdeseOverall official - principal investigator
- Ospedale civile di PescaraOverall official - principal investigator
- University of Naples Frederico IIOverall official - principal investigator
- University of MilanOverall official - principal investigator
- University of Buenos AiresOverall official - principal investigator
- Nizam's Institute of Medical Sciences, Hyderabad, IndiaOverall official - principal investigator
- Ospedale della Misericordia - GrossetoOverall official - principal investigator
- Lewisham UniversityOverall official - principal investigator
- Hospital Barros Luco TrudeauOverall official - principal investigator
- Vita-Salute University of Milano. ItalyOverall official - principal investigator
- Universidad Complutense de MadridOverall official - principal investigator
- University of CambridgeOverall official - principal investigator
- University of GenoaOverall official - principal investigator
- All India Institute of Medical SciencesOverall official - principal investigator
- Jaslok Hospital and Research Centre, Mumbai, IndiaOverall official - principal investigator
- BYL Nair HospitalOverall official - principal investigator
- National Institute of Mental Health and Neuro Sciences, IndiaOverall official - principal investigator
- Rajiv Gandhi University of Health SciencesOverall official - principal investigator
- University of BariOverall official - principal investigator
- University of LondonOverall official - principal investigator
- Autonomous University of MadridOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.